Work in progress
We are establishing a pipeline of academic and translational research projects that complement each other with the goal of developing novel anti-aging therapies. Under this scheme, the basic knowledge obtained about the process of aging is rapidly transformed into innovative strategies to develop the next generation of anti-aging molecules capable of slowing down or reversing the aging process.
Pipeline
Academic Research
Design
Funding
Execution
Manuscript
Publication
- Evaluating the relevance of premature aging models for aging research
- Investigating the amelioration of aging by in vivo reprogramming
- Establishing novel epigenetic clocks
- Investigating the physiology of aging
- Developing novel mouse models for induction of tissue-specific reprogramming
- Studying the role of epigenetic dysregulation as driver of aging
- Analyzing the improvement of aging hallmarks by reprogramming
- Discoverying novel reprogramming factors for the reversal of aging
Translational Research
Design
Investment
Execution
IP Filing
Translation
- Discoverying novel molecules for the epigenetic reprogramming of aging
- Establishing screening platforms for the discovery on anti-aging molecules
- Developing novel strategies to target the epigenome